Skip to content
Relatix Bio

Relatix Bio

Radically different

  • Services
  • Knowledgebase
  • Partnerships
  • Our Approach
  • Contact
  • About
    • Vision
    • Our mission
    • Privacy Policy
    • FAQ
    • News
Posted on June 26, 2026 by admin
<![CDATA[New phase 3 analyses show centanafadine improves adult ADHD executive function and emotional regulation beyond core symptoms, as FDA review advances toward July 2026.]]>
CategoriesImported News TagsADHD, Clinical trial, Cognitive focus and executive control, News Approved

Post navigation

Previous PostPrevious Nipah and Hendra Viruses: Antibody Cocktail Provides Complete Protection in Hamster Model
Next PostNext Intravesical CAR T-Cell Therapy Reduces Bladder Cancer Growth in Preclinical Model

This is the footer

Privacy Policy Proudly powered by WordPress